Candel Therapeutics Inc. (CADL)
6.91
-0.93 (-11.86%)
At close: Jan 15, 2025, 1:34 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | 125.00K | 125.00K | 125.00K | 125.00K |
| Cost of Revenue | 23.98M | 987.00K | 232.00K | n/a | 6.61M |
| Gross Profit | -23.98M | -862.00K | -107.00K | 125.00K | -6.48M |
| Operating Income | -38.39M | -34.72M | -25.73M | -13.81M | -9.04M |
| Interest Income | n/a | 490.00K | 53.00K | 111.00K | 1.07M |
| Pretax Income | -37.94M | -18.79M | -36.12M | -17.68M | -8.24M |
| Net Income | -37.94M | -2.87M | -36.18M | -22.17M | -8.01M |
| Selling & General & Admin | 14.41M | 14.06M | 10.67M | 5.18M | 2.56M |
| Research & Development | 24.51M | 20.79M | 15.18M | 8.75M | 6.61M |
| Other Expenses | -24.51M | -48.00K | -1.08M | -624.00K | -571.00K |
| Operating Expenses | 14.41M | 34.80M | 24.77M | 13.31M | 8.59M |
| Interest Expense | 514.00K | 490.00K | 53.00K | n/a | n/a |
| Selling & Marketing Expenses | 687.00K | n/a | n/a | n/a | n/a |
| Cost & Expenses | 38.39M | 34.80M | 24.77M | 13.31M | 8.59M |
| Income Tax | n/a | -15.93M | 53.00K | 4.49M | -226.00K |
| Shares Outstanding (Basic) | 28.94M | 28.82M | 28.69M | 29.15M | 29.15M |
| Shares Outstanding (Diluted) | 28.94M | 28.82M | 28.69M | 29.15M | 29.15M |
| EPS (Basic) | -1.31 | -0.1 | -1.26 | -0.76 | -0.27 |
| EPS (Diluted) | -1.31 | -0.1 | -1.26 | -0.76 | -0.27 |
| EBITDA | -37.43M | -17.32M | -25.49M | -13.72M | -8.20M |
| Depreciation & Amortization | 960.00K | 987.00K | 232.00K | 91.00K | 43.00K |